Blackhill Capital Inc Eli Lilly & CO Transaction History

Blackhill Capital Inc

$1.73 Billion
Q3 2024

A detailed history of Blackhill Capital Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Blackhill Capital Inc holds 147,163 shares of LLY stock, worth $113 Million. This represents 7.52% of its overall portfolio holdings.

Number of Shares

147,163

Previous 147,198 0.02%

Holding current value

$113 Million

Previous $133 Million 2.17%

% of portfolio

7.52%

Previous 8.28%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $27,024 - $33,600	-35 Reduced 0.02%	147,163 $130 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $144,974 - $181,808	-200 Reduced 0.14%	147,198 $133 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $607,005 - $812,087	-1,025 Reduced 0.69%	147,398 $115 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $1.73 Million - $2.04 Million	3,290 Added 2.27%	148,423 $86.5 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $86,940 - $119,859	-200 Reduced 0.14%	145,133 $78 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $105,222 - $140,694	-300 Reduced 0.21%	145,333 $68.2 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $465,945 - $547,230	-1,500 Reduced 1.02%	145,633 $50 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $112,542 - $131,134	-350 Reduced 0.24%	147,133 $53.8 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $59,296 - $67,574	-200 Reduced 0.14%	147,483 $47.7 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $83,619 - $98,181	-300 Reduced 0.2%	147,683 $47.9 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $9,387 - $11,666	-40 Reduced 0.03%	147,983 $42.4 Million
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $857,252 - $1.13 Million	-6,571 Reduced 4.25%	148,023 $25 Million
Q1 2020 May 12, 2020	SELL	$119.05 - $147.35 $180,003 - $222,793	-1,512 Reduced 0.97%	154,594 $21.4 Million
Q4 2019 Feb 10, 2020	BUY	$106.92 - $132.43 $116,115 - $143,818	1,086 Added 0.7%	156,106 $20.5 Million
Q3 2019 Nov 07, 2019	SELL	$106.79 - $116.16 $110,741 - $120,457	-1,037 Reduced 0.66%	155,020 $17.3 Million
Q1 2019 May 02, 2019	SELL	$111.31 - $131.02 $775,051 - $912,292	-6,963 Reduced 4.27%	156,057 $20.3 Million
Q4 2018 Jan 31, 2019	SELL	$105.9 - $118.64 $4,765 - $5,338	-45 Reduced 0.03%	163,020 $18.9 Million
Q2 2018 Aug 06, 2018	BUY	$75.7 - $86.88 $529,900 - $608,160	7,000 Added 4.49%	163,065 $13.9 Million
Q1 2018 May 08, 2018	BUY	$74.21 - $87.6 $89,051 - $105,120	1,200 Added 0.77%	156,065 $12.1 Million
Q4 2017 Feb 05, 2018	SELL	$81.94 - $87.89 $4,097 - $4,394	-50 Reduced 0.03%	154,865 $13.1 Million
Q3 2017 Nov 02, 2017	BUY	$77.07 - $85.54 $11.9 Million - $13.3 Million	154,915	154,915 $13.3 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackhill Capital Inc, based on Form 13F filings with the SEC.

News

Stay updated on Blackhill Capital Inc with notifications on news.

Account

Blackhill Capital Inc Eli Lilly & CO Transaction History